Status:
COMPLETED
Pharmacokinetics of Vancomycin in Adults Receiving ECMO
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Extracorporeal Membrane Oxygenation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
1. Vancomycin is a drug that requires precise dosing and close monitoring to avoid drug toxicity. 2. There is limited data on the change of vancomycin pharmacokinetics in patients who need extracorpor...
Detailed Description
1. Vancomycin is a drug that requires precise dosing and close monitoring to avoid drug toxicity. 2. Oftentimes it is used in intensive care units (ICU) for patients who need a life-saving machine for...
Eligibility Criteria
Inclusion
- \>18 y/o
- receiving ECMO for study group
- without ECMO for control group (sex, age, creatinine clearance match with study group)
Exclusion
- severe burn (\>30-40% BSA)
- receiving continuous renal replacement therapy or hemodialysis concurrently
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2007
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00281281
Start Date
December 1 2005
End Date
April 1 2007
Last Update
December 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 10051